- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 17.09. | As Trump visits UK, GSK pledges $30bn in US investment | ||
| 17.09. | AZ's bid for Fasenra approval in COPD falls short | ||
| 17.09. | Flood of warning letters follows DTC ad clampdown | ||
| 16.09. | Study finds Novo's Wegovy turns down 'food noise' | ||
| 16.09. | Imfinzi becomes first NHS drug for aggressive lung cancer | ||
| 16.09. | FDA's Makary explains 'overdue' pharma ads crackdown | ||
| 16.09. | RFK Jr expands ACIP ahead of highly anticipated meeting | ||
| 15.09. | Novo's oral GLP-1 is first to claim heart health label | ||
| 15.09. | Novartis agrees $5.7bn degrader deal with Monte Rosa | ||
| 15.09. | Rumour mill has Camurus buying partner Braeburn | ||
| 15.09. | AbbVie loses bid to block 340B law in Mississippi | ||
| 15.09. | High dose of Wegovy drives weight loss to 19% | ||
| 12.09. | Reaction to MSD's UK exit as government tries to renew talks | ||
| 12.09. | Camino and Jazz take top honours at rebranded PMi Awards 2025 | ||
| 12.09. | Apple Watch hypertension feature cleared by FDA | ||
| 12.09. | Lilly loses bid to nix $184m Medicaid fraud penalty | ||
| 11.09. | Intercept pulls Ocaliva off the market in the US | ||
| 11.09. | AbbVie lifted by lengthy delay to generics of Rinvoq | ||
| 11.09. | J&J claims FDA okay for bladder cancer drug TAR-200 | ||
| 11.09. | Zentiva set to change hands in €4.1bn private equity deal | ||
| 11.09. | Pharma says UK is 'tumbling down' rankings for investment | ||
| 11.09. | Fresh blow to UK life sciences as MSD abandons £1bn project | ||
| 10.09. | New CEO to slash 9,000 jobs at Novo Nordisk in restructure | ||
| 10.09. | HHS, FDA drop major DTC advertising policy changes | ||
| 09.09. | Lilly lines up Julianne Moore to front brain health campaign |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .